Brief: SkinBioTherapeutics Says Co Appointed Alyson Levett To Oversee Continuing Investigation Process
20/02/2026 07:29
Feb 20 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS - INDEPENDENT INVESTIGATION APPOINTMENT SKINBIOTHERAPEUTICS: APPOINTED NON-EXEC DIRECTOR & AUDIT COMMITTEE CHAIR, ALYSON LEVETT, TO OVERSEE CONTINUING INVESTIGATION PROCESS ON BOARD BEHALF SKINBIOTHERAPEUTICS PLC - APPOINTS FRP ADVISORY FOR FORENSIC REVIEW Source text: ID:nRST7469Ta Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company